Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry
…, MM Luckey, RW Downs Jr, BC Lentle - Journal of Clinical …, 2005 - Elsevier
Measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) is
used to diagnose osteoporosis, assess the risk of fracture, and monitor changes in BMD over …
used to diagnose osteoporosis, assess the risk of fracture, and monitor changes in BMD over …
Bisphosphonate associated osteonecrosis of the jaw
…, E Peters, DA Hanley, SR Chaudry, B Lentle… - The Journal of …, 2009 - jrheum.org
In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving
bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving …
bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving …
[HTML][HTML] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
…, R Josse, DL Kendler, B Lentle… - … England Journal of …, 1997 - Mass Medical Soc
Background and Methods Osteoporosis is a recognized complication of corticosteroid
therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, …
therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, …
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children: a report from the Canadian Panel of …
…, RG Josse, DL Kendler, ES Leib, BC Lentle… - Journal of Clinical …, 2004 - Elsevier
The Canadian Panel of the International Society for Clinical Densitometry has developed
standards in order to establish the minimum level of acceptable performance for the practice of …
standards in order to establish the minimum level of acceptable performance for the practice of …
Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid‐Associated Osteoporosis in the …
…, M Matzinger, N Shenouda, B Lentle… - Journal of Bone and …, 2009 - academic.oup.com
… (B) The morphology of vertebral fractures in relation to location and frequency among … (B)
The morphology of vertebral fractures in relation to location and frequency among children with …
The morphology of vertebral fractures in relation to location and frequency among children with …
Comparison of fracture risk prediction among individuals with reduced and normal kidney function
Results There were 320 individuals with an eGFR< 60 ml/min per 1.73 m 2 and 1787 with
an eGFR≥ 60 ml/min per 1.73 m 2. The mean age was 67±10 years and 71% were women. …
an eGFR≥ 60 ml/min per 1.73 m 2. The mean age was 67±10 years and 71% were women. …
Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study
…, R Stein, D Stephure, S Taback, B Lentle… - Arthritis care & …, 2012 - Wiley Online Library
Objective To determine the frequency of incident vertebral fractures (IVF) 12 months after
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …
High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy
…, J Hay, S Israels, C Laverdiere, B Lentle… - Journal of clinical …, 2012 - ascopubs.org
Purpose Vertebral fractures due to osteoporosis are a potential complication of childhood
acute lymphoblastic leukemia (ALL). To date, the incidence of vertebral fractures during ALL …
acute lymphoblastic leukemia (ALL). To date, the incidence of vertebral fractures during ALL …
[PDF][PDF] Recommendations for bone mineral density reporting in Canada
Objective: To propose a set of recommendations for optimal bone mineral density (BMD)
reporting in postmenopausal women and older men and to provide clinicians with both a BMD …
reporting in postmenopausal women and older men and to provide clinicians with both a BMD …
Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances
…, YM Vigna, SI Barr, C Rexworthy, BC Lentle - The American journal of …, 1994 - Elsevier
objective: Bone loss occurs in young women who experience amenorrhea or ovulatory
disturbances. The purpose of this study was to determine whether bone loss could be prevented …
disturbances. The purpose of this study was to determine whether bone loss could be prevented …